What's new in cardiovascular prevention?
This review is essentially a summary of the 2007 version of the European guidelines on cardiovascular disease prevention in clinical practice recently published by the 4th JointTask Force. New data from the guidelines in the fields of the general objectives in lifestyle modifications and drug therapies are emphasised. Recent studies on antioxydant vitamins, homocysteine-lowering vitamins and HDL-Cholesterol raising drugs are also being discussed.
Brohet
C R
CR
Cliniques Universitaires Saint Luc, Service de Pathologie cardio-vasculaire, Avenue Hippocrate 10, 1200 Bruxelles, Belgium. brohet@card.ucl.ac.be
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005060:Europe; D006801:Humans; D008019:Life Style; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D016896:Treatment Outcome; D014815:Vitamins / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D000975:Antioxidants; D014815:Vitamins